CUE – cue biopharma, inc. (US:NASDAQ)

News

Cue Biopharma Announces Pricing of $10 Million Public Offering [Yahoo! Finance]
Cue Biopharma Announces Pricing of $10 Million Public Offering
Cue Biopharma Announces Proposed Public Offering
Cue Biopharma (NASDAQ:CUE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Cue Biopharma (NASDAQ:CUE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com